Phase I/II study of bortezomib-melphalan-prednisolone for previously untreated Japanese patients with multiple myeloma.
Ogawa Y, Suzuki K, Sakai A, Iida S, Ogura M, Tobinai K, Matsumoto M, Matsue K, Terui Y, Ohashi K, Ishii M, Mukai HY, Ando K, Hotta T.
Ogawa Y, et al. Among authors: iida s.
Cancer Sci. 2013 Jul;104(7):912-9. doi: 10.1111/cas.12172. Epub 2013 May 27.
Cancer Sci. 2013.
PMID: 23574271
Free PMC article.
Clinical Trial.